2.710USD-3.39%Mkt Cap: 244.51M USDP/E: —Last update: 2026-06-01
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap244.51M USD
Enterprise Value259.55M USD
Revenue (TTM)78.09M USD
Gross Profit61.05M USD
Net Income (TTM)-43.97M USD
Revenue/Share0.8750 USD
Last Price2.710 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees146
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS1920051067
Valuation
P/E (Trailing)—
P/E (Forward)-7.49
PEG13.53
EV/EBITDA-12.63
EV/Revenue3.32
P/S3.22
P/B5.82
EPS (TTM)-0.35
EPS (Forward)-0.37
52W Range
0.960060% of range3.870
52W High3.870 USD
52W Low0.9600 USD
Profitability
Gross Margin86.73%
Oper. Margin-52.75%
EBITDA Margin-26.31%
Profit Margin-62.47%
ROE-87.03%
ROA-29.75%
Growth
Revenue Growth102.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.38M USD
CapEx (TTM)4.47M USD
FCF Margin-10.85%
FCF Yield-3.47%
Net Debt7.76M USD
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity1.45
Current Ratio5.36
Quick Ratio4.93
Book Value/Sh0.4760 USD
Cash/Share0.7170 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)6.583 USD
Target Range2.000 USD – 11.00 USD
# Analysts6
Ownership
Shares Out.90.90M
Float72.98M
Insiders7.41%
Institutions74.36%
Short Interest
Short Ratio2.9d
Short % Float4.13%
Short % Out.4.07%
Shares Short3.70M
Short (prev mo.)6.28M
Technical
SMA 502.316 (+17.0%)
SMA 2002.042 (+32.7%)
Beta2.53
S&P 52W Chg27.94%
Avg Vol (30d)1.05M
Avg Vol (10d)753.70K
Technical Indicators
RSI (14)61.0
MACD0.0804
MACD Signal0.0824
MACD Hist.-0.0020
BB Upper2.834 USD
BB Middle2.606 USD
BB Lower2.377 USD
BB Width17.55%
ATR (14)0.1847 USD
Vol Ratio (20d)0.62x